Senior Accounting Manager

Does it excite you to work with external financial reporting and technical IFRS accounting? If this sounds like you, and you are ready to take on a broad area of responsibilities, then you could be our new colleague. ​ 

Your new position 
As our new Senior Accounting Manager, you will play a central role in Zealand Pharma’s external financial reporting and technical accounting. The role spans quarterly and annual reporting, IFRS assessments for complex transactions, and cross-functional controlling and improvement projects. You will report to the Head of Reporting & Analytics and collaborate closely with Financial Controlling & Operations, Investor Relations, and external auditors to ensure high-quality and timely deliverables. 

We offer exciting responsibilities: 

• Lead preparation of quarterly earnings materials, including financial statements, notes, management commentary, and supporting analyses
• Coordinate inputs to the Annual Report per IFRS and Danish requirements; ensure accuracy, completeness, and consistency of disclosures
• Act as key point of contact for external auditors during quarterly reviews and annual audits; coordinate inputs from internal stakeholders
• Prepare and document technical accounting assessments (e.g., partnerships, collaborations, licensing, acquisitions, financing, complex contracts) and align with auditors
• Support month-end close with analytical controls; maintain accounting policies and the accounting manual
• Drive or support finance projects (systems improvements, process automation, implementation of new standards) and continuous improvement initiatives

Your profile 
A current or former auditor with strong IFRS capabilities and a structured, proactive approach. Thrives in a cross-functional environment, communicates clearly with stakeholders, and brings a willingness to take initiatives. Digitally savvy and comfortable with modern finance and reporting tools.

Substantial audit/assurance experience from a reputable firm (e.g., Big Four or equivalent).

• Proven knowledge of IFRS and technical accounting analyses
• Experience with consolidations, ERP, and financial reporting tools, e.g. Konsolidator, Microsoft D365 Finance & Operations
• Strong analytical problem-solving skills and attention to detail
• Effective stakeholder management and clear communication in English
• Nice to have: experience in biotech/pharma, life sciences, or R&D-intensive environments

Your new team 
You will join Finance & Accounting, reporting to the Head of Reporting & Analytics, and working closely with Financial Controlling & Operations and colleagues across Finance. The team’s purpose is to support value creation through efficient, high-quality, and user-centric financial processes, collaborating with internal stakeholders and external auditors to deliver on key priorities.  

Let’s bond and be bold ​ 
We have a unique culture, characterized by excellent teamwork and strong engagement across the organization. And we want you to help us strengthen this culture.

Making bonds is at the core of everything we do. From discovering and developing the best new peptide drugs for patients, to engaging with our partners or connecting with each other. We bond through curiosity and playfulness as a team, allowing ourselves to challenge common thinking and drive future innovation. Join us and let's bond and be bold.

Interested in bonding with us? Then please apply no later than February 6, 2026, or as soon as possible. The applications will be reviewed as they come in. While a cover letter is not required, please include a few sentences in your CV explaining your motivation for applying.

For further information, please contact Head of Reporting & Analytics, Martin Lyders Larsen; [email protected].

We are committed to an inclusive recruitment process and welcome applications from all job applicants. 

About Zealand Pharma A/S  

Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand Pharma have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. The company has development partnerships with a number of pharma companies as well as commercial partnerships for its marketed products. Zealand Pharma was founded in 1998 and is headquartered in Copenhagen, Denmark, with a team in the U.S. For more information about Zealand Pharma's business and activities, please visit www.zealandpharma.com.